Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Enzinger

Showing results (101-110 of 199) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904Matthew H Kulke, Margaret A Tempero, Donna Niedzwiecki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 3, 2022
Racial and ethnic disparities in cancer caregiver burden and potential sociocultural mediatorsAnny T H R Fenton, Katherine A Ornstein, Peggye Dilworth-Anderson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2016
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosisM Khalil, A Renner, C Langkammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapyJeffrey A Meyerhardt, Denise Heseltine, Hannia Campos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, et al.
Future Oncology (London, England)|May 2, 2024
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinomaJong-Mu Sun, Antoine Adenis, Peter C Enzinger, et al.
Journal of Pain and Symptom Management|October 5, 2022
Cancer Caregivers' Prognostic and End-of-Life Communication Needs and Experiences and their ImpactAnny T H R Fenton, Kalen M Fletcher, Deniz Kizildag, et al.
Journal of Pain and Symptom Management|December 26, 2024
"You Want to Shield Your Kids": Patients' and Their Adult-Children's Serious Illness ConversationsAnny Thr Fenton, Bernadette Blashill, Anna C Revette, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 1, 2017
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosisM M Voortman, T Pekar, D Bachmayer, et al.
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
Pageof 20

Showing results (101-110 of 199) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904Matthew H Kulke, Margaret A Tempero, Donna Niedzwiecki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 3, 2022
Racial and ethnic disparities in cancer caregiver burden and potential sociocultural mediatorsAnny T H R Fenton, Katherine A Ornstein, Peggye Dilworth-Anderson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2016
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosisM Khalil, A Renner, C Langkammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapyJeffrey A Meyerhardt, Denise Heseltine, Hannia Campos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, et al.
Future Oncology (London, England)|May 2, 2024
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinomaJong-Mu Sun, Antoine Adenis, Peter C Enzinger, et al.
Journal of Pain and Symptom Management|October 5, 2022
Cancer Caregivers' Prognostic and End-of-Life Communication Needs and Experiences and their ImpactAnny T H R Fenton, Kalen M Fletcher, Deniz Kizildag, et al.
Journal of Pain and Symptom Management|December 26, 2024
"You Want to Shield Your Kids": Patients' and Their Adult-Children's Serious Illness ConversationsAnny Thr Fenton, Bernadette Blashill, Anna C Revette, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 1, 2017
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosisM M Voortman, T Pekar, D Bachmayer, et al.
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
Pageof 20